AGT and esophageal squamous cell carcinoma: Although several experimental and epidemiological studies have suggested that angiotensin II/AT1R/AT2R may be involved in the development or progression of a variety of cancers, little is known about the role of the angiotensin II/AT1R/AT2R signaling pathway in ESCC.